A retrospective characterization of worsening renal function in patients with acute decompensated heart failure receiving nesiritide

Nesiritide is approved by Food and Drug Administration (FDA) for the treatment of patients with acute decompensated heart failure (ADHF) due its ability to rapidly reduce cardiac filling pressures and improve dyspnea. Numerous studies have shown that renal dysfunction is associated with unfavorable...

Descripción completa

Detalles Bibliográficos
Autores principales: Starr, Jessica A., Nappi, Jean M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2009
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139050/
https://www.ncbi.nlm.nih.gov/pubmed/25143796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139050/
https://www.ncbi.nlm.nih.gov/pubmed/25143796

Ejemplares similares